Top Stories
-
Through a trial offered at Columbia, a patient who is ineligible for existing treatments is the first to receive an experimental gene therapy.
Topic
-
Columbia scientists have found that breast cancer patients who are HIV-positive are 40% more likely to have triple-negative breast cancer—the most aggressive subtype—than patients without HIV.
Topic
-
Norovirus, the most common stomach bug in the United States, makes the rounds every winter. Our expert GI doctor gives tips on how to avoid this highly contagious illness and what to do if you get it.
Topic
-
Researchers have learned how to stimulate the immune system in animal models to produce large quantities of broadly neutralizing antibodies against HIV—a prerequisite for an effective vaccine.
Topic
Latest News
- October 19, 2020
New data from Columbia and other ECMO centers throughout the world show that more than 60% of severe COVID-19 patients who receive ECMO, a heart-lung life support machine, survive.
Topic
- October 16, 2020
People with congenital heart disease had a lower-than-expected risk for severe symptoms from COVID-19, a new study has found.
Topic
- October 15, 2020
Flu season is coming—how will the influenza vaccine be different in the era of COVID-19? Columbia’s David Buchholz, MD, explains.
Topic
- October 15, 2020
Outbreaks of SARS-CoV-2 may become a regular occurrence depending on the risk of reinfection, vaccine availability and efficacy, and interactions with other viruses, Mailman researchers say.
Topic
- October 12, 2020
Moms with COVID-19 who take basic precautions rarely pass the virus to their newborns, even if breastfeeding and rooming together, finds a new study at Columbia University and NewYork-Presbyterian.
Topic
- October 5, 2020
Video lectures and virtual labs from the Mailman School of Public Health's two-day "COVID-19 From Virus to Vaccine" course in late August are now online and available to all.
Topic
- September 24, 2020
As members of a Testing Innovation Council, Mailman scientists helped evaluate diagnostic technologies to support the city’s need for rapid testing.
Topic
- September 21, 2020
Months after recovering from a mild case of COVID-19, even healthy young adults are experiencing memory problems, fatigue, mood changes, and other neurological and psychiatric issues.
Topic
- September 8, 2020
Experts on convalescent plasma discuss why randomized clinical trials of the treatment in COVID-19 patients are more important than ever.
Topic
- September 4, 2020
After the pandemic forced many scientists to put studies on pause, VP&S and other CUIMC researchers are back on campus with a renewed sense of purpose.
Topic
